Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Atreca Q2 EPS $(0.72), Same YoY

Atreca (NASDAQ:BCEL) reported quarterly losses of $(0.72) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

August 8, 2022

1 minute read

Atreca (NASDAQ:BCEL) reported quarterly losses of $(0.72) per share. This is unchanged from the same period last year.

News

Playtika’s Game Studio Wooga Launches Switchcraft, A New Story-Driven Match 3 Game

By Benzinga Newsdesk

Today, 10:53 AM

Playtika Holding corp. (NASDAQ:PLTK) today announced the global launch of Switchcraft, developed by its Berlin-based game studio Wooga GmbH. Switchcraft is a casual game that marries interactive, narrative

PLTK

Asbury Automotive Q4 Earnings Beat Street View; Boosts Buyback

By Shivani Kumaresan

Today, 10:53 AM

Asbury Automotive Group Inc (NYSE:ABG) reported fourth-quarter FY21 sales growth of 19% year-on-year, to $2.65 billion, beating the analyst consensus of…

ABG

Earnings

Cellectar Biosciences: Q2 Earnings Insights

By Benzinga Insights

Today, 10:53 AM

Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

CLRB

Monopar Therapeutics Q2 EPS $(0.17) Down From $(0.14) YoY

By Bill Haddad

Today, 10:53 AM

Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.17) per share. This is a 21.43 percent decrease over losses of $(0.14) per share from the same period last year.

MNPR

Atreca Q2 EPS $(0.72), Same YoY

Related Posts

Playtika’s Game Studio Wooga Launches Switchcraft, A New Story-Driven Match 3 Game

Asbury Automotive Q4 Earnings Beat Street View; Boosts Buyback

Cellectar Biosciences: Q2 Earnings Insights

Monopar Therapeutics Q2 EPS $(0.17) Down From $(0.14) YoY